Evidence map›Paper›PMID 18404378›Full record

ArticleNeurochemical research2009

Developmental regulation of TREM2 and DAP12 expression in the murine CNS: implications for Nasu-Hakola disease.

J Cameron Thrash, Bruce E Torbett, Monica J Carson

Open access · greenAbstract read
In one paragraph

Article in Neurochemical research, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 101 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Letter to the Editor: Novel TREM2 frameshift mutation in a 30-year-old woman with suspected frontotemporal dementia.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2023
    Article
  6. Microglial TREM2 at the Intersection of Brain Aging and Alzheimer's Disease.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2023
    Review
  7. Review
  8. The Primary Microglial Leukodystrophies: A Review.International journal of molecular sciences · 2022
    Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

J Cameron ThrashDivision of Biomedical Sciences, Center for Glial-Neuronal Interactions, University of California Riverside, 900 University Ave, Riverside, CA, 92521, USA.
Bruce E Torbett
Monica J Carson
University of California, Riverside · USScripps Research Institute · US

Funding

MOLECULES OF ACTIVATED MICROGLIAR01NS039508 · NINDS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI CARSON, MONICA J · 2000 to 2004
$1.4M
Triggering Receptors and CNS InflammationR01NS045735 · NINDS · UNIVERSITY OF CALIFORNIA RIVERSIDE · PI CARSON, MONICA J · 2003 to 2006
$1.3M
NINDS NIH HHS NS045735NINDS NIH HHS NS39508NINDS NIH HHS R01 NS039508NINDS NIH HHS R01 NS045735
6 · The paper itself

Abstract

Trem2 is an orphan, DAP12 associated receptor constitutively expressed in vivo by subsets of microglia in the healthy adult murine CNS and in vitro by subsets of oligodendrocytes in neonatal mixed glial cultures. Loss of a functional Trem2 signaling pathway is the genetic cause of Nasu-Hakola disease. Whether the early onset cognitive dementia and myelin-pallor associated with this disorder are due to deficits in functional Trem2 signaling in microglia and/or oligodendrocytes is still being debated. Here, we find that Trem2/DAP12 expression is detected in embryonic day 14 CNS mRNA. Using dual immunohistochemistry/in situ hybridization, we find that both Trem2 and DAP12 expression always co-localized with markers of microglia/macrophages. However, Trem2/DAP12 positive microglia are found in very close apposition with CNP+ oligodendrocytes prior to myelination (post-natal day 1). In addition, CNS expression of TREM2 and DAP12 are not detected in PU.1KO which lack microglia and macrophages. Our data provide continuing support for Nasu-Hakola disease being identified as a cognitive disorder caused by a primary dysfunction of CNS microglia.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsBone DiseasesCentral Nervous SystemDementia, VascularGene Expression Regulation, DevelopmentalHeredodegenerative Disorders, Nervous SystemHumansMembrane GlycoproteinsMiceMice, Inbred C57BLMicrogliaReceptors, ImmunologicRNA, MessengerSignal TransductionAdaptor Proteins, Signal TransducingMembrane GlycoproteinsReceptors, ImmunologicRNA, MessengerTrem2 protein, mouseTyrobp protein, mouse

Identifiers

PMID18404378
PMCPMC2655126
OpenAlexW1965165023

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.